STML

7:00 am Stemline Therapeutics announces FDA acceptance of IND for SL-701, a synthetic multi-peptide vaccine targeting glioma brain tumors

moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

STEMLINE THERAPEUTICS INC Financials

moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics to Present at Cowen and Company Health Care Conference

[GlobeNewswire] – NEW YORK — Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’s CEO, will present at the Cowen and Company 34th Annual Health Care Conference on Tuesday, March 4, 2014 at … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to […]

Stemline Therapeutics to Present at Citi 2014 Global Healthcare and RBC Capital Markets Conferences

[GlobeNewswire] – NEW YORK — Stemline Therapeutics, Inc. announced today that it will present at the Citi 2014 Global Healthcare and RBC Capital Markets Global Healthcare conferences in February. moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics (STML) Soars: Stock Up 17.5%

moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics Reports Year-End 2012 Financial Results

[at noodls] – NEW YORK, April 1, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML) (the Company), a clinical-stage biopharmaceutical company developing oncology therapeutics that target … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics to Present at Leerink Swann and Company Global Healthcare Conference

[at noodls] – NEW YORK, Feb. 12, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics, Inc. to Present at BIO CEO & Investor Conference on February 11th

[at noodls] – NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]

Stemline Therapeutics, Inc. Announces Pricing of Initial Public Offering of 3,317,644 Shares of Common Stock

[at noodls] – NEW YORK, Jan. 28, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor … moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]